Your selection basket is empty.
Define a selection of ETFs which you would like to compare.
Add an ETF by clicking "Compare" on an ETF profile or by checkmarking an ETF in the ETF search.
Travere Therapeutics
ISIN US89422G1076
|WKN A2QHYP
Market cap (in EUR)
2,258 m
Country
United States
Sector
Healthcare
Dividend yield
0.00%
Overview
Description
Travere Therapeutics, Inc. is a biopharmaceutical company. It engages in the identification, development, commercialization, and distribution of therapies to people living with rare diseases. The firm's products include Chenodal, Cholbam, and Thiola. The company was founded by Martin Shkreli on February 7, 2008 and is headquartered in San Diego, CA.
Healthcare Biopharmaceuticals System-Specific Biopharmaceuticals United States
Financials
Key metrics
| Market capitalisation, EUR | 2,258 m |
| EPS, EUR | -0.98 |
| P/B ratio | 36.6 |
| P/E ratio | - |
| Dividend yield | 0.00% |
Income statement (2024)
| Revenue, EUR | 216 m |
| Net income, EUR | -296 m |
| Profit margin | -137.51% |
What ETF is Travere Therapeutics in?
There are 24 ETFs which contain Travere Therapeutics. All of these ETFs are listed in the table below. The ETF with the largest weighting of Travere Therapeutics is the L&G Pharma Breakthrough UCITS ETF.
Order fees
Here you can find information about different brokers that allow you to trade stocks. Select your preferred order volume to compare the fees charged by the respective brokers.
Order volume:
| Broker | Rating | Order fee | Stock savings plans | |
|---|---|---|---|---|
 | 0.99€ | 3000 | View offer** | |
 | 0.00€ | 5600 | View offer* | |
 | 1.00€ | 2500 | View offer* | |
 | 9.95€ | 5000 | View offer* | |
 | 0.00€ | 2500 | View offer* |
Source: justETF Research; as of 2/2026. The offers are sorted in the following way: 1. Rating 2. Order fee 3. Number of stock savings plans. The number of stock savings plans is rounded. In addition to the fees charged by online brokers, additional costs may apply. The stated fees are thus exclusive of standard market spreads, commissions, product costs and third-party fees. Please note: No guarantee can be given for the completeness, correctness and accuracy of the content listed. The information on the online brokers' homepages is decisive. Investments in securities involve risks.
*Affiliate link
** Important note: We are part of the Scalable Group since 2021 and are a wholly owned subsidiary of Scalable GmbH. In order to avoid conflicts of interest as far as possible, we have always applied neutral, objectively verifiable criteria to all comparisons, articles and tests, and attach great importance to YOU alone deciding how and with whom you invest.
*Affiliate link
** Important note: We are part of the Scalable Group since 2021 and are a wholly owned subsidiary of Scalable GmbH. In order to avoid conflicts of interest as far as possible, we have always applied neutral, objectively verifiable criteria to all comparisons, articles and tests, and attach great importance to YOU alone deciding how and with whom you invest.
Savings plan offers
Here you can find information about the savings plan availability for the stock. You can use the table to compare savings plan offers for the selected savings rate.
Source: justETF Research; as of 2/2026. The offers are sorted in the following way: 1. Rating 2. Execution fee 3. Number of stock savings plans. The number of stock savings plans is rounded. In addition to the fees charged by online brokers, additional costs may apply. The stated fees are thus exclusive of standard market spreads, commissions, product costs and third-party fees. Please note: No guarantee can be given for the completeness, correctness and accuracy of the content listed. The information on the online brokers' homepages is decisive. Investments in securities involve risks.
*Affiliate link
** Important note: We are part of the Scalable Group since 2021 and are a wholly owned subsidiary of Scalable GmbH. In order to avoid conflicts of interest as far as possible, we have always applied neutral, objectively verifiable criteria to all comparisons, articles and tests, and attach great importance to YOU alone deciding how and with whom you invest.
*Affiliate link
** Important note: We are part of the Scalable Group since 2021 and are a wholly owned subsidiary of Scalable GmbH. In order to avoid conflicts of interest as far as possible, we have always applied neutral, objectively verifiable criteria to all comparisons, articles and tests, and attach great importance to YOU alone deciding how and with whom you invest.
Latest articles
— Data provided by Trackinsight, etfinfo, Xignite Inc., gettex, FactSet and justETF GmbH. Quotes are either real-time (gettex) or 15 minutes delayed stock exchange quotes or NAVs (daily published by the fund provider). By default, ETF returns include dividend payments (if applicable). There is no warranty for completeness, accuracy and correctness for the displayed information.